Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Evolocumab After Thrombectomy for Atherosclerotic Acute Ischemic Stroke
NCT07295366Phase 4Completed
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Dec 2025
- Primary completion
- May 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of evolocumab in ischemic stroke, sponsored by The Affiliated Hospital of Xuzhou Medical University. Started Dec 2025; status: completed.
02
Drugs
evolocumab
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07295366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07295366.